Choong Ang Vaccine Laboratory Co (XKRX:072020) Total Liabilities : ₩17,377 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Choong Ang Vaccine Laboratory Co Total Liabilities?

Choong Ang Vaccine Laboratory Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩17,377 Mil.

Choong Ang Vaccine Laboratory Co's quarterly Total Liabilities declined from Sep. 2023 (₩21,017.65 Mil) to Dec. 2023 (₩19,788.30 Mil) and declined from Dec. 2023 (₩19,788.30 Mil) to Mar. 2024 (₩17,376.56 Mil).

Choong Ang Vaccine Laboratory Co's annual Total Liabilities declined from Dec. 2021 (₩19,976.15 Mil) to Dec. 2022 (₩19,554.13 Mil) but then increased from Dec. 2022 (₩19,554.13 Mil) to Dec. 2023 (₩19,788.30 Mil).

Choong Ang Vaccine Laboratory Co Total Liabilities Historical Data

The historical data trend for Choong Ang Vaccine Laboratory Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Choong Ang Vaccine Laboratory Co Total Liabilities Chart

Choong Ang Vaccine Laboratory Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

10,200.16

17,429.39

19,976.15

19,554.13

19,788.30

Choong Ang Vaccine Laboratory Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															18,614.12	19,922.16	21,017.65	19,788.30	17,376.56

Choong Ang Vaccine Laboratory Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Choong Ang Vaccine Laboratory Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12652.855	+	(6819.533	+	-8.5265128291212E-13
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	315.911)
	=	19,788

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	119592.514	-	99804.215
	=	19,788

Choong Ang Vaccine Laboratory Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11218.132	+	(5760.69	+	2.3305801732931E-12
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	397.739)
	=	17,377

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	117341.046	-	99964.485
	=	17,377

Choong Ang Vaccine Laboratory Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Choong Ang Vaccine Laboratory Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Choong Ang Vaccine Laboratory Co (XKRX:072020) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Choong Ang Vaccine Laboratory Co Ltd (XKRX:072020) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

1476-37 Yongsan-dong, Yuseong-gu, Daejeon, KOR, 305-348

Website

http://www.cavac.co.kr

Choong Ang Vaccine Laboratory Co., Ltd. manufactures and markets vaccines for animals. The company specialized in vaccines for animals and is the largest one in Korea. The company has a solid financial structure.

Choong Ang Vaccine Laboratory Co (XKRX:072020) Headlines

No Headlines